BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hui AM, Cui X, Makuuchi M, Li X, Shi YZ, Takayama T. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma. Hepatology 1999;30:1167-73. [PMID: 10534337 DOI: 10.1002/hep.510300506] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Macias RIR, Cardinale V, Kendall TJ, Avila MA, Guido M, Coulouarn C, Braconi C, Frampton AE, Bridgewater J, Overi D, Pereira SP, Rengo M, Kather JN, Lamarca A, Pedica F, Forner A, Valle JW, Gaudio E, Alvaro D, Banales JM, Carpino G. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022:gutjnl-2022-327099. [PMID: 35580963 DOI: 10.1136/gutjnl-2022-327099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yamashita T, Kato K, Fujihara S, Iwama H, Morishita A, Yamana H, Kobayashi K, Kamada H, Chiyo T, Kobara H, Tsutsui K, Okano K, Suzuki Y, Masaki T. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest. Anticancer Drugs. 2020;31:231-240. [PMID: 31815765 DOI: 10.1097/cad.0000000000000870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, Pereira SP, Cadamuro M, Rupp C, Loosen SH, Luedde T, Banales JM. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver Int. 2019;39 Suppl 1:108-122. [PMID: 30843325 DOI: 10.1111/liv.14090] [Cited by in Crossref: 30] [Cited by in F6Publishing: 54] [Article Influence: 15.0] [Reference Citation Analysis]
4 Guan G, Bakr MM, Firth N, Love RM. Expression of cyclin D1 correlates with p27KIP1 and regulates the degree of oral dysplasia and squamous cell carcinoma differentiation. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2018;126:174-83. [DOI: 10.1016/j.oooo.2018.01.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Samukawa E, Fujihara S, Oura K, Iwama H, Yamana Y, Tadokoro T, Chiyo T, Kobayashi K, Morishita A, Nakahara M, Kobara H, Mori H, Okano K, Suzuki Y, Himoto T, Masaki T. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest. Int J Oncol 2017;51:1674-84. [PMID: 29075786 DOI: 10.3892/ijo.2017.4177] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
6 Xing Cui, Song Li, Shraim A, Kobayashi Y, Hayakawa T, Kanno S, Yamamoto M, Hirano S. Subchronic Exposure to Arsenic Through Drinking Water Alters Expression of Cancer-Related Genes in Rat Liver. Toxicol Pathol 2004;32:64-72. [DOI: 10.1080/01926230490261348] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
7 Liu L, Cui X, Sakaguchi T, Sasaki M, Suda T, Hatakeyama K. Expression of p73 in Colorectal Carcinoma: Clinicopathological Relevance. J Int Med Res 2001;29:297-303. [DOI: 10.1177/147323000102900406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li C, Li X, Wu L, Jiang Z. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma. Technol Cancer Res Treat 2017;16:421-7. [PMID: 27143047 DOI: 10.1177/1533034616646288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Jones RP, Bird NT, Smith RA, Palmer DH, Fenwick SW, Poston GJ, Malik HZ. Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers. Biomark Med 2015;9:763-75. [PMID: 26223884 DOI: 10.2217/BMM.15.48] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
10 Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, Cheng JD, Alpaugh RK, Cooper H, Wright JJ, Cohen SJ. A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers. Clin Colorectal Cancer 2014;13:81-6. [PMID: 24512954 DOI: 10.1016/j.clcc.2013.12.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ruys AT, Groot Koerkamp B, Wiggers JK, Klümpen H, ten Kate FJ, van Gulik TM. Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis. Ann Surg Oncol 2014;21:487-500. [DOI: 10.1245/s10434-013-3286-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
12 Grossman EJ, Millis JM. Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature. Liver Transpl. 2010;16:930-942. [PMID: 20677284 DOI: 10.1002/lt.22106] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
13 Won HS, Lee MA, Chung ES, Kim DG, You YK, Hong TH, Lee IS. Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer. BMC Cancer 2010;10:564. [PMID: 20955617 DOI: 10.1186/1471-2407-10-564] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
14 Kim WB, Han HJ, Lee HJ, Park SS, Song TJ, Kim HK, Suh SO, Kim YC, Choi SY. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer. Ann Surg Oncol. 2009;16:23-34. [PMID: 18979138 DOI: 10.1245/s10434-008-0182-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
15 Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP. Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer. 2009;45:33-47. [PMID: 18938071 DOI: 10.1016/j.ejca.2008.08.024] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
16 Zhou L, He XD, Cui QC, Zhou WX, Qu Q, Zhou RL, Rui JA, Yu JC. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Lett 2008;264:209-17. [PMID: 18334282 DOI: 10.1016/j.canlet.2008.01.025] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
17 Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Hum Pathol 2008;39:710-9. [PMID: 18329694 DOI: 10.1016/j.humpath.2007.09.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
18 Cormier JN, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol. 2000;16:437-443. [PMID: 17031117 DOI: 10.1097/00001574-200009000-00009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Saigusa K, Hashimoto N, Tsuda H, Yokoi S, Maruno M, Yoshimine T, Aoyagi M, Ohno K, Imoto I, Inazawa J. Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas. Cancer Sci 2005;96:676-83. [PMID: 16232199 DOI: 10.1111/j.1349-7006.2005.00099.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
20 Hasebe T, Konishi M, Iwasaki M, Endoh Y, Nakagohri T, Takahashi S, Kinoshita T, Ochiai A. Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study. Hum Pathol 2005;36:655-64. [PMID: 16021572 DOI: 10.1016/j.humpath.2005.04.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
21 Shi G, Yang P, Chen X. Expression and clinical significance of p27kip1 protein in primary liver cancer. J Huazhong Univ Sci Technolog Med Sci 2004;24:588-90. [PMID: 15791849 DOI: 10.1007/BF02911363] [Reference Citation Analysis]
22 Sanada T, Yokoi S, Arii S, Yasui K, Imoto I, Inazawa J. Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers. Cancer Sci. 2004;95:969-976. [PMID: 15596046 DOI: 10.1111/j.1349-7006.2004.tb03185.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
23 Feakins RM, Nickols CD, Bidd H, Walton SJ. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Hum Pathol. 2003;34:1276-1282. [PMID: 14691913 DOI: 10.1016/j.humpath.2003.07.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
24 Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Monden M, Matsuura N. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma. Liver. 2002;22:145-149. [PMID: 12028409 DOI: 10.1034/j.1600-0676.2002.01532.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
25 Suzuoki M, Hida Y, Miyamoto M, Oshikiri T, Hiraoka K, Nakakubo Y, Shinohara T, Itoh T, Okushiba S, Kondo S. RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma. Ann Surg Oncol. 2002;9:388-393. [PMID: 11986191 DOI: 10.1007/bf02573874] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
26 Guo SS, Wu X, Shimoide AT, Wong J, Sawicki MP. Anomalous overexpression of p27(Kip1) in sporadic pancreatic endocrine tumors. J Surg Res 2001;96:284-8. [PMID: 11266285 DOI: 10.1006/jsre.2001.6085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
27 Li X, Hui A, Takayama T, Cui X, Shi Y, Makuuchi M. Altered p21WAF1/CIP1 expression is associated with poor prognosis in extrahepatic bile duct carcinoma. Cancer Letters 2000;154:85-91. [DOI: 10.1016/s0304-3835(00)00383-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
28 Hui AM, Li X, Shi YZ, Torzilli G, Takayama T, Makuuchi M. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis. Hepatology 2000;31:1068-72. [PMID: 10796881 DOI: 10.1053/he.2000.6127] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]